Table of Contents
- 1 Monash University – ASPREE – Login page
- 2 Aspree
- 3 ASPREE EAC
- 4 Aspree USA | SITES – Aspree USA
- 5 Aspirin in Reducing Events in the Elderly – ASPREE
- 6 Monash University – ASPREE – Password Recovery
- 7 ASPREE Australia | HOW IS MY PRIVACY PROTECTED? – ASPREE …
- 8 ASPREE – Wiki Journal Club
- 9 ASPREE Australia | Studying the effect of aspirin on …
- 10 ASPREE SCIENTIFIC SUMMARY – ASPREE Australia
Monash University – ASPREE – Login page
welcome to the aspree-xt web data entry login page This site is intended for data entry by research staff in regional centres over Australia and ASPREE hubs in USA
USA Website. Australian Website
ASPREE Endpoint Adjudication Committee Log In. User Name: * Password: *
Aspree USA | SITES – Aspree USA
ASPREE Trial Centers Map above: Location of sites that conducted the ASPREE clinical trial in US. The ASPREE clinical trial has concluded, with the main results published in 2018.
Aspirin in Reducing Events in the Elderly – ASPREE
McNeil JJ, Nelson MR, Woods RL, et al., on behalf of the ASPREE Investigator Group. Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. N Engl J Med 2018;379:1519-28. McNeil JJ, Wolfe R, Woods RL, et al., on behalf of the ASPREE Investigator Group. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Monash University – ASPREE – Password Recovery
Step 4: Retrieve new password from email and return to login page. If the email address is not current, you will need to email ASPREE IT Staff: (AU) firstname.lastname@example.org (US) email@example.com
ASPREE Australia | HOW IS MY PRIVACY PROTECTED? – ASPREE …
The ASPREE study protects the privacy of participants in a number of ways: … Access to this web-based portal is only made available to registered study staff via a password-protected and secure login. Data held at the ASPREE Clinical Trial Centre is locked within a secure environment both physically (paper files) and electronically. …
ASPREE – Wiki Journal Club
The Aspirin in Reducing Events in the Elderly (ASPREE; 2018) trial enrolled 19,114 healthy elderly patients (≥70 years old, ≥65 years old in Hispanic or Black patients) without a history of CVD, cerebrovascular disease, dementia, or any other chronic condition that would likely limit survival to less than 5 years.
ASPREE Australia | Studying the effect of aspirin on …
ASPREE (ASPirin in Reducing Events in the Elderly) is a large, primary prevention aspirin study in healthy older people in Australia and the USA. ASPREE Australia. Studying the effect of aspirin on healthy lifespan. ASPirin in Reducing Events in the Elderly 1800 728 745. HOME; ABOUT US.
ASPREE SCIENTIFIC SUMMARY – ASPREE Australia
ASPREE protocol summary. ASPREE is a double-blind, randomised, placebo-controlled primary prevention trial designed to assess whether daily active treatment of 100 mg enteric-coated aspirin will extend the duration of disability-free life in healthy participants aged 70 years and above.